Skip to main content

Clarivate

Clarivate Names 22 Citation Laureates, Honoring GLP-1 Drug Pioneers

Image
Clarivate Names 22 Citation Laureates, Honoring GLP-1 Drug Pioneers

London – September 19, 2026 -- Clarivate Plc (NYSE: CLVT) named 22 researchers as its Citation Laureates 2026, identifying scientists whose work the company's Institute for Scientific Information (ISI) considers Nobel-class ahead of this year's Nobel Prize announcements. Since the program began in 2002, 89 previously named Citation Laureates have gone on to win Nobel Prizes.

Study Challenges Fear-Based Sales Pitch, Finds 31% Recall Gain

Image
Study Challenges Fear-Based Sales Pitch, Finds 31% Recall Gain

Waltham, Mass. – September 18, 2026 -- Sales messages that tell B2B technology buyers they control a positive outcome hold attention 31% longer and produce 31% better recall than fear-based pitches, according to new neuroscience research from Allego, Inc. that challenges a nearly 50-year-old sales doctrine.

The study, conducted with cognitive neuroscientist Dr. Carmen Simon of Enhancive, tests the real-world application of Prospect Theory, the 1979 model by Daniel Kahneman and Amos Tversky holding that fear of loss motivates buyers more than potential gain. Kahneman won the 2002 Nobel Memorial Prize in Economics partly for that work.